Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients

被引:27
作者
Gu, Bai-Wei [1 ]
Apicella, Marisa [1 ]
Mills, Jason [2 ]
Fan, Jian-Meng [1 ]
Reeves, Dara A. [1 ]
French, Deborah [2 ]
Podsakoff, Gregory M. [3 ]
Bessler, Monica [1 ]
Mason, Philip J. [1 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Div Hematol, Philadelphia, PA 19104 USA
来源
PLOS ONE | 2015年 / 10卷 / 05期
基金
美国国家卫生研究院;
关键词
SMALL NUCLEOLAR RNA; CRYSTAL-STRUCTURE; SELF-RENEWAL; MUTATIONS; CANCER; LGR5; ELONGATION; EXPRESSION; DEFECTS; COMPLEX;
D O I
10.1371/journal.pone.0127414
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by the presence of short telomeres at presentation. Mutations in ten different genes, whose products are involved in the telomere maintenance pathway, have been shown to cause DC. The X-linked form is the most common form of the disease and is caused by mutations in the gene DKC1, encoding the protein dyskerin. Dyskerin is required for the assembly and stability of telomerase and is also involved in ribosomal RNA (rRNA) processing where it converts specific uridines to pseudouridine. DC is thought to result from failure to maintain tissues, like blood, that are renewed by stem cell activity, but research into pathogenic mechanisms has been hampered by the difficulty of obtaining stem cells from patients. We reasoned that induced pluripotent stem (iPS) cells from X-linked DC patients may provide information about the mechanisms involved. Here we describe the production of iPS cells from DC patients with DKC1mutations Q31E, A353Vand Delta L37. In addition we constructed "corrected" lines with a copy of the wild type dyskerin cDNA expressed from the AAVS1 safe harbor locus. We show that in iPS cells with DKC1mutations telomere maintenance is compromised with short telomere lengths and decreased telomerase activity. The degree to which telomere lengths are affected by expression of telomerase during reprograming, or with ectopic expression of wild type dyskerin, is variable. The recurrent mutation A353Vshows the most severe effect on telomere maintenance. A353Vcells but not Q31Eor Delta L37cells, are refractory to correction by expression of wild type DKC1 cDNA. Because dyskerin is involved in both telomere maintenance and ribosome biogenesis it has been postulated that defective ribosome biogenesis and translation may contribute to the disease phenotype. Evidence from mouse and zebra fish models has supported the involvement of ribosome biogenesis but primary cells from human patients have so far not shown defects in pseudouridylation or ribosomal RNA processing. None of the mutant iPS cells presented here show decreased pseudouridine levels in rRNA or defective rRNA processing suggesting telomere maintenance defects account for most of the phenotype of X-linked DC. Finally gene expression analysis of the iPS cells shows that WNT signaling is significantly decreased in all mutant cells, raising the possibility that defective WNT signaling may contribute to disease pathogenesis.
引用
收藏
页数:20
相关论文
共 49 条
  • [1] Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients
    Agarwal, Suneet
    Loh, Yuin-Han
    McLoughlin, Erin M.
    Huang, Junjiu
    Park, In-Hyun
    Miller, Justine D.
    Huo, Hongguang
    Okuka, Maja
    dos Reis, Rosana Maria
    Loewer, Sabine
    Ng, Huck-Hui
    Keefe, David L.
    Goldman, Frederick D.
    Klingelhutz, Aloysius J.
    Liu, Lin
    Daley, George Q.
    [J]. NATURE, 2010, 464 (7286) : 292 - U176
  • [2] Correlation between β-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma
    Austinat, Madeleine
    Dunsch, Ruediger
    Wittekind, Christian
    Tannapfel, Andrea
    Gebhardt, Rolf
    Gaunitz, Frank
    [J]. MOLECULAR CANCER, 2008, 7 (1)
  • [3] Ballew BJ, 2013, EXPERT REV HEMATOL, V6, P327, DOI [10.1586/EHM.13.23, 10.1586/ehm.13.23]
  • [4] Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells
    Batista, Luis F. Z.
    Pech, MatthewF.
    Zhong, Franklin L.
    Nguyen, Ha Nam
    Xie, Kathleen T.
    Zaug, Arthur J.
    Crary, Sharon M.
    Choi, Jinkuk
    Sebastiano, Vittorio
    Cherry, Athena
    Giri, Neelam
    Wernig, Marius
    Alter, Blanche P.
    Cech, Thomas R.
    Savage, Sharon A.
    Pera, Renee A. Reijo
    Artandi, Steven E.
    [J]. NATURE, 2011, 474 (7351) : 399 - +
  • [5] Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita
    Bellodi, Cristian
    Kopmar, Noam
    Ruggero, Davide
    [J]. EMBO JOURNAL, 2010, 29 (11) : 1865 - 1876
  • [6] Secondary structure of vertebrate telomerase RNA
    Chen, JL
    Blasco, MA
    Greider, CW
    [J]. CELL, 2000, 100 (05) : 503 - 514
  • [7] Shelterin: the protein complex that shapes and safeguards human telomeres
    de Lange, T
    [J]. GENES & DEVELOPMENT, 2005, 19 (18) : 2100 - 2110
  • [8] Dyskeratosis Congenita
    Dokal, Inderjeet
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 480 - 486
  • [9] DYSKERATOSIS-CONGENITA
    DRACHTMAN, RA
    ALTER, BP
    [J]. DERMATOLOGIC CLINICS, 1995, 13 (01) : 33 - 39
  • [10] Naf1p is a box H/ACA snoRNP assembly factor
    Fatica, A
    Dlakic, M
    Tollervey, D
    [J]. RNA, 2002, 8 (12) : 1502 - 1514